TGH, USF Health to Create New Model for Advanced Organ DiseasePublished: Jul 5, 2017
TGH, USF Health to Create New Model for Advanced Organ Disease
Tampa, FL (July 5, 2017) – Tampa General Hospital and the USF Health Morsani College of Medicine are creating a new model for advanced organ transplantation. Noted transplant physician Dr. David Weill has been named director of the new Institute for Advanced Organ Disease and Transplantation, which will bring together the four organ transplant programs under singular leadership.
The institute will serve patients in need of organ transplants or who suffer complex medical conditions as a result of advanced organ disease of the heart, lungs, liver, pancreas, and kidneys at Tampa General, already one of the nation’s busiest transplant centers, and at USF Health’s South Tampa Center for Advanced Medical Care.
“Dr. Weill’s clinical expertise and his vision for how to improve outcomes and enhance quality of care are aligned with what we’re already doing here at TGH,” said Dr. Sally Houston, chief medical officer at Tampa General. “Dr. Weill is working with our seasoned team of physicians to create a new model that will better coordinate clinical care and enhance the patient experience at all stages of organ failure.”
Dr. Charles J. Lockwood, senior vice president for USF Health and dean of the USF Health Morsani College of Medicine, says the institute will offer high-quality, integrated care with cutting-edge research designed to benefit a wide range of patients.
“In each of our transplant areas, this academic-affiliated institute will enable us to create pathways of subspecialty care to help patients with complex disorders delay or even avoid a transplant; to seamlessly transition to a transplant when needed, while minimizing postsurgical complications; and to maximize quality of life,” Dr. Lockwood said.
Dr. Weill has ambitious plans for the institute. “No matter how good our current outcomes are, we can always do better. We’re going after the most experienced physicians and we will dig deep with our research. This is critical, because it gives you better ways to improve patient outcomes, and reduce health care costs.”
Weill says the new Institute in Tampa will also work to increase clinical trials, publish more research results, and compete for more research grants. Patients will have the opportunity to participate in these trials and know that they have access to the latest advances in medical treatment. The Institute will also offer specialized fellowships, offering some of the nation’s top young doctors the opportunity to get top-level training in the complex care that patients with advanced organ disease need.
“With the vision and leadership of Dr. Weill, our partnership will dramatically advance the national visibility of the already outstanding transplant service at Tampa General Hospital by increasing academic research productivity,” Lockwood said.
“Dr. Weill will support efforts to enhance the national reputation of Tampa General Hospital’s transplant program by increasing our research efforts and continuing to recruit top notch talent,” Houston said.
Weill is the former director of the Center for Advanced Lung Disease and the Lung and Heart-Lung Transplant Program at Stanford University Medical Center. He is also past chair of the Pulmonary Transplantation Council of the International Society of Heart and Lung Transplantation. He served ten years on the editorial board of the Journal of Heart and Lung Transplantation and in several capacities for the United Network for Organ Sharing, including as a member of the Thoracic Committee, a member of the National Lung Review Board, and a member of the Membership and Professional Standards Committee.
Weill received his BA from Tulane University and his MD from Tulane University Medical School. He completed his residency at Parkland Hospital, University of Texas – Southwestern and a fellowship in Pulmonary and Critical Care Medicine and Lung Transplantation at the University of Colorado at Denver and Health Sciences Center.